Pathology internationalHumansGallbladder NeoplasmsBiomarkersTumorMale
CD109 Expression in Tumor and Stromal Cells Serves as a Prognostic Biomarker for Tumor Progression and Outcome in Gallbladder Adenocarcinoma.
Taro Kogami, Masaaki Ichinoe, Yasutaka Sakurai, Takuya Kato, Masahiro Matsushita, Akihiro Tamaki, Yurika Kesen, Shoko Hayashi, Itaru Sanoyama, Yoshiko Numata, Atsuko Umezawa, Masatoshi Ichihara, Chika Kusano, Yoshiki Murakumo
Published: 202610.1111/pin.70085
Abstract
CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is upregulated in various human cancers and exhibits tumor-promoting effects. In this study, we investigated the role of CD109 in gallbladder adenocarcinoma (GBAC). CD109 expression i…
Preview only. Read the full abstract at the source